# Madrigal Pharmaceuticals, Inc.: filings

MDGL · Nasdaq · CIK 1157601 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mdgl.md) · [Financials](/companies/mdgl/financials.md) · [Filings](/companies/mdgl/filings.md) · [Insiders](/companies/mdgl/insiders.md)

## Reports and events: 319 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 441, 8-K 183, 144 85, 10-Q 53, SC 13G/A 44, SC 13D/A 37, 3 34, 424B5 31, 10-K 18, DEF 14A 17, DEFA14A 16, S-8 15, SC 13G 15, 5 12, ARS 10, SCHEDULE 13G/A 10, 4/A 9, CORRESP 7, CT ORDER 7, UPLOAD 7, EFFECT 5, 10-K/A 4, S-3 4, 424B3 3, S-3ASR 3, 10-Q/A 2, 424B2 2, 5/A 2, PRE 14A 2, SC 13D 2, SCHEDULE 13D/A 2, 144/A 1, 424B7 1, 8-K/A 1, D 1, DEFM14A 1, NT 10-K 1, POS AM 1, PREM14A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-12 | 08:18 ET | [8-K](/filings/0001628280-26-055962.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-055962 |
| 2026-07-30 | 09:06 ET | [10-Q](/filings/0001628280-26-050845.md) | Quarterly report, period 2026-06-30 | 0001628280-26-050845 |
| 2026-07-30 | 07:03 ET | [8-K](/filings/0001628280-26-050775.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-050775 |
| 2026-06-17 | 16:06 ET | [8-K](/filings/0001104659-26-075130.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-075130 |
| 2026-05-06 | 09:04 ET | [10-Q](/filings/0001628280-26-030947.md) | Quarterly report, period 2026-03-31 | 0001628280-26-030947 |
| 2026-05-06 | 07:06 ET | [8-K](/filings/0001628280-26-030896.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-030896 |
| 2026-04-28 | 16:22 ET | [8-K](/filings/0001628280-26-027956.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-027956 |
| 2026-04-28 | 16:05 ET | [DEF 14A](/filings/0001308179-26-000352.md) | Proxy statement, period 2026-06-17 | 0001308179-26-000352 |
| 2026-02-19 | 09:09 ET | [10-K](/filings/0001628280-26-009514.md) | Annual report, period 2025-12-31 | 0001628280-26-009514 |
| 2026-02-19 | 07:05 ET | [8-K](/filings/0001628280-26-009476.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-009476 |
| 2026-01-30 | 17:00 ET | [8-K](/filings/0001104659-26-008698.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-008698 |
| 2025-12-12 | 18:10 ET | [SCHEDULE 13D/A](/filings/0001104659-25-120744.md) | Ownership report, active investor, amended | 0001104659-25-120744 |
| 2025-12-12 | 18:10 ET | [SCHEDULE 13D/A](/filings/0001104659-25-120743.md) | Ownership report, active investor, amended | 0001104659-25-120743 |
| 2025-12-11 | 16:15 ET | [8-K](/filings/0001628280-25-056533.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-056533 |
| 2025-11-04 | 09:11 ET | [10-Q](/filings/0001628280-25-048559.md) | Quarterly report, period 2025-09-30 | 0001628280-25-048559 |
| 2025-11-04 | 07:03 ET | [8-K](/filings/0001628280-25-048525.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-048525 |
| 2025-08-05 | 08:59 ET | [10-Q](/filings/0001628280-25-037613.md) | Quarterly report, period 2025-06-30 | 0001628280-25-037613 |
| 2025-08-05 | 07:05 ET | [8-K](/filings/0001628280-25-037596.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-037596 |
| 2025-07-30 | 06:30 ET | [8-K](/filings/0001104659-25-071928.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-071928 |
| 2025-07-22 | 08:29 ET | [8-K](/filings/0001628280-25-035506.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-035506 |
| 2025-06-20 | 16:04 ET | [8-K](/filings/0001628280-25-032358.md) | 5.07 Shareholder vote results | 0001628280-25-032358 |
| 2025-05-01 | 08:53 ET | [10-Q](/filings/0001628280-25-021356.md) | Quarterly report, period 2025-03-31 | 0001628280-25-021356 |
| 2025-05-01 | 07:02 ET | [8-K](/filings/0001628280-25-021314.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-021314 |
| 2025-04-29 | 16:16 ET | [DEF 14A](/filings/0001104659-25-041254.md) | Proxy statement, period 2025-06-20 | 0001104659-25-041254 |
| 2025-04-17 | 16:52 ET | [8-K](/filings/0001628280-25-018242.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-018242 |
| 2025-03-11 | 08:05 ET | [8-K](/filings/0001193125-25-051461.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-051461 |
| 2025-02-26 | 09:09 ET | [10-K](/filings/0001628280-25-007980.md) | Annual report, period 2024-12-31 | 0001628280-25-007980 |
| 2025-02-26 | 07:05 ET | [8-K](/filings/0001193125-25-035787.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-035787 |
| 2025-01-13 | 06:50 ET | [8-K](/filings/0001193125-25-004939.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-004939 |
| 2024-10-31 | 09:02 ET | [10-Q](/filings/0001628280-24-044445.md) | Quarterly report, period 2024-09-30 | 0001628280-24-044445 |
| 2024-10-31 | 07:05 ET | [8-K](/filings/0001193125-24-248137.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-248137 |
| 2024-08-07 | 08:58 ET | [10-Q](/filings/0001628280-24-035400.md) | Quarterly report, period 2024-06-30 | 0001628280-24-035400 |
| 2024-08-07 | 07:06 ET | [8-K](/filings/0001193125-24-195400.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-195400 |
| 2024-06-27 | 16:28 ET | [8-K](/filings/0001193125-24-170634.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-170634 |
| 2024-05-07 | 16:36 ET | [8-K](/filings/0001193125-24-133196.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-133196 |
| 2024-05-07 | 09:00 ET | [10-Q](/filings/0001628280-24-020865.md) | Quarterly report, period 2024-03-31 | 0001628280-24-020865 |
| 2024-05-07 | 07:06 ET | [8-K](/filings/0001193125-24-132559.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-132559 |
| 2024-04-29 | 16:49 ET | [DEF 14A](/filings/0001193125-24-122657.md) | Proxy statement, period 2024-06-25 | 0001193125-24-122657 |
| 2024-04-02 | 16:31 ET | [8-K](/filings/0001193125-24-084797.md) | 8.01 Other events | 0001193125-24-084797 |
| 2024-03-25 | 16:28 ET | [SC 13D/A](/filings/0001104659-24-038465.md) | Ownership report, active investor, amended | 0001104659-24-038465 |
| 2024-03-20 | 16:11 ET | [8-K](/filings/0001193125-24-072706.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-072706 |
| 2024-03-15 | 18:47 ET | [8-K](/filings/0001193125-24-068170.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-068170 |
| 2024-02-28 | 07:10 ET | [8-K](/filings/0001193125-24-049136.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-049136 |
| 2024-02-28 | 07:01 ET | [8-K](/filings/0001193125-24-049116.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-049116 |
| 2024-02-28 | 06:32 ET | [10-K](/filings/0001628280-24-007376.md) | Annual report, period 2023-12-31 | 0001628280-24-007376 |
| 2024-01-08 | 13:45 ET | [8-K](/filings/0001193125-24-004269.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-004269 |
| 2023-12-13 | 16:05 ET | [SC 13D/A](/filings/0001193125-23-294326.md) | Ownership report, active investor, amended | 0001193125-23-294326 |
| 2023-11-21 | 17:24 ET | [SC 13D/A](/filings/0001104659-23-120429.md) | Ownership report, active investor, amended | 0001104659-23-120429 |
| 2023-11-06 | 08:31 ET | [8-K](/filings/0001193125-23-270884.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-270884 |
| 2023-11-06 | 06:10 ET | [10-Q](/filings/0001193125-23-270803.md) | Quarterly report, period 2023-09-30 | 0001193125-23-270803 |

Page 1 of 7. [Older](/companies/mdgl/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.